Related Experiment Video

Updated: Jun 13, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence

Sandy Giuliano1, Yann Cheli, Mickaël Ohanna

  • 1Institut National de la Sante et de la Recherche Medicale U895, University of Nice Sophia-Antipolis, Nice, France.

Cancer Research
|April 15, 2010
PubMed

Insights

Microphthalmia-associated transcription factor (MITF) normally inhibits cellular senescence in melanoma. Depleting MITF activates a DNA damage response (DDR) and p53, triggering senescence and growth arrest, offering a potential therapeutic strategy.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Apoptosis and senescence are crucial cellular safeguards against uncontrolled proliferation, particularly in cancer.
  • Melanoma exhibits resistance to apoptosis, making senescence a promising therapeutic target.
  • Microphthalmia-associated transcription factor (MITF) is vital for melanoma growth, and its inhibition causes cell cycle arrest.

Purpose of the Study:

  • To investigate the role of MITF in regulating senescence in melanoma cells.
  • To explore the potential of targeting MITF for melanoma therapy.

Main Methods:

  • Long-term depletion of MITF in melanoma cell lines.
  • Analysis of morphologic and biochemical markers of senescence.
  • Assessment of DNA damage response (DDR) signaling and p53 activation.

Main Results:

  • Sustained MITF depletion induced a senescence program in melanoma cells, characterized by growth arrest.
  • MITF-silenced cells activated the DDR pathway and upregulated p53.
  • p53 was essential for the entry into senescence in these cells.

Conclusions:

  • MITF actively suppresses a lineage-restricted DDR/p53 signaling pathway to promote melanoma cell proliferation.
  • Inhibiting MITF can trigger senescence, presenting a novel therapeutic avenue for melanoma treatment.

More Related Videos

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images04:04

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images

Published on: May 19, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...